BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.090
-0.020 (-1.80%)
At close: May 7, 2026, 4:00 PM EDT
1.110
+0.020 (1.83%)
After-hours: May 7, 2026, 7:18 PM EDT
BioCardia Market Cap
BioCardia has a market cap or net worth of $11.93 million as of May 7, 2026. Its market cap has increased by 26.17% in one year.
Market Cap
11.93M
Enterprise Value
9.96M
1-Year Change
26.17%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $11.93M, a decrease of -58.98%. That is a compound annual growth rate of -8.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 11.93M | -10.11% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 13.23M |
| Passage Bio | 13.22M |
| Jupiter Neurosciences | 13.17M |
| Chemomab Therapeutics | 12.89M |
| GT Biopharma | 12.71M |
| BioVie | 12.52M |
| Kairos Pharma | 11.88M |
| CEL-SCI | 11.73M |